Company Name

Industry

Location

Revenue

Employees

CuraScript SD

Pharmaceuticals

United States, Florida

$250M to $500M

201-500

M3 Wake Research

Pharmaceuticals

United States, North Carolina

$250M to $500M

201-500

Collegium Pharmaceutical

Pharmaceuticals

United States, Massachusetts

$250M to $500M

201-500

Xeris Pharmaceuticals

Pharmaceuticals

United States, Illinois

$250M to $500M

201-500

Vanda Pharmaceuticals

Pharmaceuticals

United States, District of Columbia

$250M to $500M

201-500

Covis Pharma

Pharmaceuticals

United States, Massachusetts

$250M to $500M

201-500

HomeTown Pharmacy

Pharmaceuticals

United States, Michigan

$250M to $500M

201-500

Jurox

Pharmaceuticals

United States, Missouri

$250M to $500M

201-500

Certara Synchrogenix

Pharmaceuticals

United States, Delaware

$250M to $500M

201-500

Piramal Critical Care

Pharmaceuticals

United States, Pennsylvania

$250M to $500M

201-500

Eugia US

Pharmaceuticals

United States, New Jersey

$250M to $500M

201-500

Ortho Dermatologics

Pharmaceuticals

United States, New Jersey

$250M to $500M

201-500

Pharmatek

Pharmaceuticals

United States, California

$250M to $500M

201-500

AMAG Pharmaceuticals

Pharmaceuticals

United States, Massachusetts

$100M to $250M

201-500

Pii .

Pharmaceuticals

United States, Maryland

$100M to $250M

201-500

A&Z Pharmaceutical

Pharmaceuticals

United States, New York

$100M to $250M

201-500

Alfasigma USA

Pharmaceuticals

United States, New Jersey

$100M to $250M

201-500

Azzur Group

Pharmaceuticals

United States, Pennsylvania

$100M to $250M

201-500

Depomed

Pharmaceuticals

United States, California

$100M to $250M

201-500

Hyde Engineering + Consulting

Pharmaceuticals

United States, Colorado

$100M to $250M

201-500